Author: Admin on Thu Aug 28 22:30:03 PDT 2008
SYDNEY, Aug 29 (Reuters) - Australian shares are set for a firm end to the week on Friday, taking heart from rises in stock markets overseas after strong U.S. economic growth figures eased concerns...
Author: Admin on Thu Aug 28 22:28:31 PDT 2008
NEW YORK, Aug 28 (Reuters) - Teva Pharmaceutical Industries Ltd sued Swiss drugmaker Novartis AG and Momenta Pharmaceuticals Inc on Thursday, accusing them of infringing patents on its multiple...
Author: Admin on Thu Aug 28 05:34:29 PDT 2008
LONDON, Aug 28 (Reuters) - New screening tests and effective vaccines from Merck & Co and GlaxoSmithKline make tackling cervical cancer in poor countries a real possibility for the first time,...
Author: Admin on Wed Aug 27 19:43:11 PDT 2008
By Gene Emery BOSTON, Aug 27 (Reuters) - Two studies released on Wednesday call into question the advantage of using a blood pressure medicine and a well-known blood thinner for preventing the...
Author: Admin on Tue Aug 26 21:47:57 PDT 2008
WASHINGTON, Aug 26 (Reuters) - U.S. health regulators have called for more data before deciding whether a Johnson & Johnson experimental schizophrenia drug could be sold on...
Author: Admin on Tue Aug 26 21:21:36 PDT 2008
BOSTON, Aug 26 (Reuters) - The chief executive of Amylin Pharmaceuticals Inc said the purpose of a conference call later on Tuesday is to provide greater...
Author: Admin on Tue Aug 26 20:37:33 PDT 2008
WASHINGTON, Aug 26 (Reuters) - A new type of bird flu vaccine that uses a mock version of the virus appears to protect people against infection and is...
Author: Admin on Mon Aug 25 01:55:02 PDT 2008
PARIS, Aug 25 (Reuters) - French biotechnology firm Nicox said on Monday U.S. partner Pfizer had decided not to launch Phase III studies in Asia of an experimental treatment of glaucoma and ocular...
Author: Admin on Sun Aug 24 18:54:34 PDT 2008
Emcure Pharmaceuticals Ltd recently announced the launch of its new oncology plant at Pune. The facility is spread over an area of 70,000 sq ft. Emcure's total investment for the oncology...
Author: Admin on Thu Aug 21 19:39:23 PDT 2008
(Released at 2301 GMT Wed Aug 20) LONDON, Aug 21 (Reuters) - A new kind of cystic fibrosis drug, designed to bypass a genetic defect to treat the disease, has produced promising results in...
Author: Admin on Wed Aug 20 02:51:00 PDT 2008
Seattle Genetics Inc has initiated a Phase I clinical trial of SGN-70, a humanised monoclonal antibody targeting CD70 that is being developed as an investigational therapy for autoimmune diseases...
Author: Admin on Wed Aug 20 02:48:44 PDT 2008
MediGene AG has sold the European rights of the dermatological product Oracea for the treatment of rosacea to Galderma Laboratories Inc. By signing the contract, Galderma commits to making ...
Author: Admin on Wed Aug 20 02:44:34 PDT 2008
Dublin Research and Markets recently announced the addition of 'Indonesia Pharmaceuticals & Healthcare Report Q3 2007' to its offering. According to the report, the Indonesia pharmaceuticals ...
Author: Admin on Wed Aug 20 02:38:41 PDT 2008
Bayer Schering Pharma Singapore, a subsidiary of the German-based Bayer Schering Pharma AG announced that the Singapore Health Sciences Authority (HSA) has approved Nexavar (sorafenib) tablets ...
Author: Admin on Wed Aug 20 02:35:44 PDT 2008
The scientists at the Alzheimer's Association International Conference on Alzheimer's disease (ICAD 2008) in Chicago, revealed major breakthroughs in the treatment of Alzheimer's disease...
Author: Admin on Wed Aug 20 02:32:40 PDT 2008
Lonza is to co-develop and manufacture Novartis' biological pipeline as part of a long-term strategic partnership that has been struck between the companies. This entails the two companies working...
Author: Admin on Wed Aug 20 02:28:58 PDT 2008
Bristol-Myers Squibb has proposed to enter into an agreement to acquire ImClone Systems, the US-based developer of novel antibodies to treat cancer. The agreement will be for $ 60 per share in cash...
Author: Admin on Wed Aug 20 02:25:53 PDT 2008
European technical services and industrial engineering specialist, Imtech, recently said that it has received orders worth around Euro 40 million from Belgian firms like Janssen Pharmaceutica,...
Author: Admin on Wed Aug 20 02:21:12 PDT 2008
GlaxoSmithKline (GSK) is launching a new concept that will tap the highest quality thinking in academia to optimise the early clinical development of new GSK medicines in a model of shared risk and...
Author: Admin on Wed Aug 20 02:14:45 PDT 2008
ClinPhone and Cytel Inc have announced a unique partnership that unites Cytel's validated adaptive trial statistical and computational expertise with ClinPhone's clinical technologies. This...
How to end its power shortage
The following is a series of measures Beijing has taken to reduce...
What Studies You Pay for
Researchers Look at Random Sex, Beauty, and the Obvious...
